Journal of Jilin University Medicine Edition ›› 2016, Vol. 42 ›› Issue (02): 370-374.doi: 10.13481/j.1671-587x.20160234

Previous Articles     Next Articles

Value of adenosine triphosphate stressand rest nuclide myocardial perfusion imaging in diagnosis of female patients with coronary heart disease

JIANG Wenping1, HOU Sen2, LIN Qiuyu2, GU Li1, ZHAO Hongguang2   

  1. 1. Department of Nuclear Medicine, Jilin Oilfield General Hospital, Songyuan 138006, China;
    2. Department of Nuclear Medicine, First Hospital, Jilin University, Changchun 130021, China
  • Received:2015-07-15 Published:2016-03-31

Abstract:

Objective: To evaluate the value of adenosine triphophate (ATP) stress/rest nuclide myocardial perfusion imaging(MPI) in the diagnosis of female patients with coronary heart disease(CHD).Methods: The clinical materials of 47 female suspected CHD patients were retrospectively analyzed, aged from 39 to 74 years, and the average age was (53.7±6.3) years old.All patients were hospitalized and underwent two-day ATP stress and rest nuclide MPI and coronary angiography(CAG) in two weeks.The results and images of MPI and CAG were evaluated by more than 2 attending physicians.Using CAG as the "gold standard", the diagnostic efficiency (sensitivity, specificity and accuracy) of MPI for CHD was evaluated.Results: Compared with CAG, the sensitivity, specificity and accuracy of ATP stress MPI in diagnosing the female CHD patients were 81.3%(13/16), 77.4%(24/31)and 78.7%(37/47) individually;the positive predictive value and negative predictive value were 65.0%(13/20)and 88.9%(24/27).There were no severe adverse effects in the ATP stress test and the incidence of adverse effects was 85.1%.Conclusion: There is a highly diagnostic efficiency of ATP stress MPI in the CHD patients.It can be the first choice of examination methods for screening without injury and diagnosing the myocardial ischemia in the female patients.

Key words: adenosine triphosphate, myocardial perfusion imaging, coronary heart disease, female

CLC Number: 

  • R817.4